GTN most commonly stands for glyceryl trinitrate, a fast-acting medication used to relieve chest pain caused by angina. It works by relaxing blood vessels, improving blood flow to the heart within one to five minutes. In oncology, GTN can also stand for gestational trophoblastic neoplasia, a group of rare pregnancy-related cancers.
GTN as a Heart Medication
Glyceryl trinitrate (also called nitroglycerin, especially in the United States) is one of the oldest and most widely used treatments for angina, the chest pain that occurs when the heart muscle doesn’t get enough blood. It comes as a sublingual tablet you place under your tongue or as a spray you use on or under your tongue. Both forms work quickly, typically providing relief in one to five minutes.
GTN is used in two ways: to stop an angina attack that’s already happening, and to prevent one you can see coming. If you know a specific activity triggers your symptoms, like exercise or physical exertion, you can use a dose beforehand. Clinical guidelines recommend using the spray while seated, since it can cause a sudden drop in blood pressure that makes you dizzy or lightheaded if you’re standing.
How GTN Works in the Body
Once absorbed, GTN converts into nitric oxide, a molecule that signals the smooth muscle in blood vessel walls to relax. This relaxation is especially strong in the veins. When veins widen, blood pools in them rather than rushing back to the heart. That reduces the volume of blood the heart has to pump with each beat, which lowers its workload and oxygen demand. The result is less chest pain.
The effect on arteries also helps by slightly widening the coronary arteries themselves, allowing more blood to reach the heart muscle. But the primary benefit comes from that reduction in how hard the heart has to work, not from dramatically increasing blood supply.
Dosage and How to Use It
The standard approach is one tablet under the tongue or one to two sprays at the first sign of chest pain. If the pain doesn’t ease after five minutes, you can take a second dose. A third dose can follow five minutes after that. The firm rule: no more than three doses in 15 minutes. If your chest pain hasn’t resolved after three doses, that’s a medical emergency.
Tablets dissolve under the tongue and should not be chewed or swallowed. The spray delivers the medication in the same area. Both bypass the digestive system entirely, which is why they act so fast.
Side Effects and Key Interactions
Headache is the most common side effect by a wide margin, affecting more than one in ten people who use GTN. It happens because the same blood vessel relaxation that helps the heart also widens blood vessels in the head. Facial flushing is also reported. A drop in blood pressure when standing up (orthostatic hypotension) is common enough that sitting down before using the medication is standard advice.
The most important safety concern is the interaction with erectile dysfunction medications like sildenafil (Viagra), tadalafil (Cialis), and similar drugs. Both GTN and these medications work on the same pathway in blood vessel walls. GTN floods the system with nitric oxide, while erectile dysfunction drugs prevent the body from breaking down the chemical signal that nitric oxide triggers. Together, they can cause a dangerous, potentially life-threatening drop in blood pressure. Research in men with angina found that this interaction persists for at least eight hours after taking sildenafil. Using the two together is strictly contraindicated.
GTN in Oncology
In cancer medicine, GTN stands for gestational trophoblastic neoplasia, a group of rare malignant tumors that develop from placental tissue during or after pregnancy. These cancers arise from trophoblast cells, the cells that normally form the outer layer of the placenta. GTN includes several subtypes: invasive mole, choriocarcinoma (a particularly aggressive form), placental-site trophoblastic tumor, and epithelioid trophoblastic tumor.
GTN most often develops after a molar pregnancy, a condition where abnormal tissue grows in the uterus instead of a normal embryo. About 15 to 20 percent of complete molar pregnancies progress to GTN. The progression rate after partial molar pregnancies is much lower, between 0.5 and 5 percent. All of these tumors can spread to other parts of the body and can be fatal without treatment.
How GTN Cancer Is Detected
After a molar pregnancy, doctors monitor blood levels of hCG, the hormone that pregnancy tests detect. In a normal recovery, hCG levels drop steadily back to zero. If levels plateau or start rising again instead, that’s the primary signal that the molar pregnancy may have progressed to GTN. Most cases of post-molar GTN are caught through this blood monitoring alone, before any symptoms appear.
Once diagnosed, GTN is staged using a system that combines the tumor’s anatomical spread with a risk scoring index. This scoring system accounts for factors like the patient’s age, the time since the pregnancy, tumor size, whether the cancer has spread, and hCG levels. The total score classifies the cancer as low risk or high risk, which determines treatment intensity. The good news: GTN is one of the most curable cancers, with high survival rates even in advanced cases when treated appropriately.